A recent review has noted that this pattern of clinical presentation is more similar to that seen in familial cases of Alzheimer’s disease caused by mutations in APP that decrease amyloid-β40/42 ratio, than to cases of diseases caused by duplication of APP (Zis and Strydom, 2018). Here, APP is linked to Alzheimer disease.